Abstract:Crimean-Congo haemorrhagic fever virus (CCHFV) is a highly pathogenic virus for which a safe and effective vaccine is not yet available, despite being considered a priority emerging pathogen. Understanding transmission patterns and the use of potential effective vaccines are central elements of the future plan against this infection. We developed a series of models of transmission amongst livestock, and spillover infection into humans. We use real-world human and animal data from a CCHFV endemic area in Afghanistan (Herat) to calibrate our models. We assess the value of environmental drivers as proxy indicators of vector activity, and select the best model using deviance information criteria. Finally we assess the impact of vaccination by simulating campaigns targeted to humans or livestock, and to high-risk subpopulations (i.e, farmers). Saturation deficit is the indicator that better explains tick activity trends in Herat. Recent increments in reported CCHFV cases in this area are more likely explained by increased surveillance capacity instead of changes in the background transmission dynamics. Modelling suggests that clinical cases only represent 31% (95% CrI 28%-33%) of total infections in this area. Vaccination campaigns targeting humans would result in a much larger impact than livestock vaccination (266 vs 31 clinical cases averted respectively) and a more efficient option when assessed in courses per case averted (35 vs 431 respectively). Targeted vaccination of farmers is impactful and more efficient, resulting in 19 courses per case averted (95% CrI 7–62) compared to targeting the general population (35 courses 95% CrI 16–107) CCHFV is endemic in Herat, and transmission cycles are well predicted by environmental drivers like saturation deficit. Vaccinating humans is likely to be more efficient and impactful than animals, and importantly targeted interventions to high risk groups like farmers can offer a more efficient approach to vaccine roll-out. Crimean-Congo haemorrhagic fever virus (CCHF) is an understudied emerging pathogen and the cause of increasingly frequent outbreaks of haemorrhagic fever in humans in several parts of the world. Here we bring together an important body of work in different aspects of the ecology and epidemiology of CCHF to shed light on its transmission dynamics into humans and the role of environmental drivers. These results show that over the years an endemic pattern of CCHFV transmission has been established within livestock, and the frequency of human cases mirrors the seasonal pattern of livestock transmission. Our analysis further suggests that an important fraction of cases in humans might be subclinical, and the volume of transmission into humans might be much larger than previously thought. We examine the potential impact of vaccination, which suggest that not only human vaccination could be more impactful than animal vaccination, but also that targeted strategies in human high risk groups could be very effective. Our results raise important insights for future vaccine development and important questions on the optimal conditions for conducting Phase III vaccine trials in humans.

Crimean–Congo haemorrhagic fever virus uses LDLR to bind and enter host cells

LDLR is an entry receptor for Crimean-Congo hemorrhagic fever virus

LDLR is used as a cell entry receptor by multiple alphaviruses

The low-density lipoprotein receptor promotes infection of multiple encephalitic alphaviruses

Porcine low-density lipoprotein receptor plays an important role in classical swine fever virus infection

Antibodies targeting Crimean-Congo hemorrhagic fever virus GP38 limit vascular leak and viral spread

Distinguishing host responses, extensive viral dissemination and long-term viral RNA persistence in domestic sheep experimentally infected with Crimean-Congo haemorrhagic fever virus Kosovo Hoti

Pathogenesis of Crimean–Congo Hemorrhagic Fever From an Immunological Perspective

Neutralizing monoclonal antibodies against the Gc fusion loop region of Crimean–Congo hemorrhagic fever virus

Nucleocapsid protein-specific monoclonal antibodies protect mice against Crimean-Congo hemorrhagic fever virus

Structural and functional basis of VLDLR usage by Eastern equine encephalitis virus

Low-Density Lipoprotein Receptor (LDLR) Is Involved in Internalization of Lentiviral Particles Pseudotyped with SARS-CoV-2 Spike Protein in Ocular Cells

CCR2 is a host entry receptor for severe fever with thrombocytopenia syndrome virus

Crimean Congo Hemorrhagic Fever Virus for Clinicians-Virology, Pathogenesis, and Pathology

The VLDLR entry receptor is required for the pathogenesis of multiple encephalitic alphaviruses

Development of targeted whole genome sequencing approaches for Crimean-Congo haemorrhagic fever virus (CCHFV)

The current pathogenicity and potential risk evaluation of Crimean-Congo hemorrhagic fever virus to cause mysterious "Disease X"-An updated literature review

Control strategies for emerging infectious diseases: Crimean-Congo hemorrhagic fever management

Crimean-Congo Hemorrhagic Fever Virus for Clinicians-Epidemiology, Clinical Manifestations, and Prevention

Purification and characterization of soluble recombinant Crimean-Congo hemorrhagic fever virus glycoprotein Gc expressed in mammalian 293F cells

Transmission dynamics and vaccination strategies for Crimean-Congo haemorrhagic fever virus in Afghanistan: A modelling study